Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia
Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
BMJ Open. 2024 Jul 11;14(7):e080670. doi: 10.1136/bmjopen-2023-080670.
This study explored potential quality measures to improve skin cancer management in primary care settings, and the barriers and facilitators associated with their implementation.
Semistructured interviews and qualitative proforma surveys were conducted with skin cancer experts from a range of healthcare settings. Framework analysis was employed to identify key groups of quality measures within the domains of the Donabedian model of healthcare quality (structure, process, outcome). Interview and survey data were triangulated to identify common groups of quality measures, barriers and facilitators.
We purposively recruited skin cancer experts from Australia and internationally with knowledge and experience in skin cancer management. The final sample consisted of 15 participants who had clinical or academic backgrounds.
Participants unequivocally expressed the need for quality measures to guide skin cancer care. Ten groups of quality measures were identified: three groups related to the structural elements of care (eg, diagnostic tools), four related to the processes of care (eg, diagnostic process) and three related to outcomes of care (eg, treatment outcomes). Implementation barriers included clinician resistance, system inadequacies and external factors (eg, patient risk). Facilitators included incentives, education, agreed and feasible indicators and support and guidance.
To service a growing population of skin cancer patients in Australia, the role of primary care needs to be more clearly specified, and its care providers supported and more engaged in quality improvement processes. Structure, process and outcome quality measures, derived from detailed guidance for primary care settings, can be used to track practitioner performance and facilitate ongoing improvement.
本研究旨在探讨改善初级保健环境中皮肤癌管理的潜在质量指标,以及与这些指标实施相关的障碍和促进因素。
对来自不同医疗保健环境的皮肤癌专家进行半结构式访谈和定性专题调查。采用框架分析方法,在医疗保健质量的多贝迪安模型(结构、过程、结果)的各个领域内确定质量指标的关键组别。访谈和调查数据的三角分析用于确定共同的质量指标、障碍和促进因素组别。
我们有意从澳大利亚和国际上招募具有皮肤癌管理知识和经验的皮肤癌专家。最终样本由 15 名参与者组成,他们具有临床或学术背景。
参与者明确表示需要质量指标来指导皮肤癌护理。确定了 10 组质量指标:三组与护理结构要素有关(如诊断工具),四组与护理过程有关(如诊断过程),三组与护理结果有关(如治疗结果)。实施障碍包括临床医生的抵触、系统不足和外部因素(如患者风险)。促进因素包括激励措施、教育、达成共识且可行的指标以及支持和指导。
为了满足澳大利亚日益增长的皮肤癌患者群体的需求,需要更明确地规定初级保健的作用,并支持和更多地让初级保健提供者参与质量改进过程。源自对初级保健环境的详细指导的结构、过程和结果质量指标可用于跟踪医生的表现并促进持续改进。